Pharmafile Logo
Pharmafocus logo
Advanced Search
dementia image

Dementia project pays out £50 million

July 26, 2013
Medical Communications, Sales and Marketing Jeremy Hunt, dementia

Over a hundred hospitals and care homes across England have been awarded a share of a £50million fund to help …

News
BMS image

Sharp fall in sales for Bristol-Myers Squibb

July 26, 2013
Sales and Marketing Avapro, BMS, Plavix, Q2

Bristol-Myers Squibb has seen a fall in sales over the past three months as it struggles with major patent losses. …

News
Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

News
Lonza image

Teva and Lonza abandon biosimilars joint venture

July 26, 2013
Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars

Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …

News
finbarr-martin-bw

Two non-executive directors join NICE Board

July 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NICE, finbarr martin, mumford

The Department of Health has announced that two new non-executive directors will join the National Institute for Health and Care …

Appointment
Roche image

Strong growth for Roche in latest results

July 25, 2013
Sales and Marketing Alexion, Q2, Rituxan, Roche

Roche has seen strong sales growth in the past six months as it lines up new products to replace its …

News

UK rejects meningitis B vaccine Bexsero

July 25, 2013
Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b

The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …

News
GSK image

Actions in China ‘shameful’ says GSK boss

July 25, 2013
Medical Communications, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …

News
andrew_monaghan_chiltern__jul_2013

Chiltern hires Andrew Monaghan as director

July 25, 2013
Manufacturing and Production, Research and Development, Sales and Marketing CRO, chiltern, monaghan

Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …

Appointment
Benlysta image

Benlysta once again rejected by NICE

July 25, 2013
Sales and Marketing Benlysta, GSK, NHS, NICE

NICE has opened a second public consultation for GSK’s lupus drug Benlysta after the Institute has again rejected the medicine …

News
AMRI image

AMRI says troubled Burlington plant back on track

July 24, 2013
Manufacturing and Production AMRI, FDA, GMP

It looks like contract research and manufacturing organisation AMRI can put the quality problems at its facility in Burlington behind …

News
gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

News
lilly image

Transition Therapeutics buys into Lilly bone drug

July 24, 2013
Research and Development, Sales and Marketing Transition, bone, lilly

Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …

News
Roche image

New Roche leukaemia drug beats rival

July 24, 2013
Research and Development, Sales and Marketing Rituxan, Roche, leukaemia, obinutuzumab

Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …

News
richard bergstrom image

Pharma groups want limited data release

July 24, 2013
Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency

The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …

News

Professor Trevor Jones CBE appointed chairman of Simbec Research

July 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, simbec, trevor jones

Clinical research organisation Simbec Research has appointed Professor Trevor Jones CBE as non-executive chairman of the Board of directors. Jones …

Appointment
AstraZeneca image

AstraZeneca staff questioned in China

July 23, 2013
Medical Communications, Sales and Marketing AstraZeneca, China, GSK, bribery

AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …

News
Merck image

MSD cleared by PMCPA

July 23, 2013
Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

News
wockhardt image

FDA warning letter for troubled Wockhardt plant

July 23, 2013
Manufacturing and Production FDA, Wockhardt, warning

The US regulator has issued a warning letter to a facility operated by Indian drugmaker Wockhardt already subject to an …

News
manufacturing image

Pharma manufacturing news in brief

July 23, 2013
Manufacturing and Production Fujifilm, Molecular Profiles, Penn Pharma, Rafarma, Riboxx Pharma, United Arab Emirates

UAE ‘s bid to boost domestic drug industry plus facility updates from Penn Pharma and Molecular Profiles head our round-up …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026